Simpler Grants.gov #U54

Forecasted Renewal of NIH NHGRI AnVIL Cloud Genomics Platform Program

The National Institutes of Health (NIH), through the National Human Genome Research Institute (NHGRI), is forecasting a limited competition grant opportunity for the renewal of the Analysis, Visualization, and Informatics Lab-space (AnVIL) program. - Government Buyer: - National Institutes of Health (NIH) - National Human Genome Research Institute (NHGRI) - Program Overview: - AnVIL is a secure, cloud-based platform supporting access, sharing, and analysis of large-scale genomic datasets - Currently hosts over 5 petabytes of data from nearly 300,000 participants - Products/Services Requested: - Enhancement and renewal of the AnVIL platform as a community resource - Focus on scalability, interoperability with NIH data systems, and robust security (including RAS and CADR compliance) - Integration of new data types and computational tools, including infrastructure for AI-based methods and complex analysis workflows - Expansion of training and outreach to support effective use of AnVIL - Unique/Notable Requirements: - Emphasis on FAIR (Findable, Accessible, Interoperable, Reusable) data principles - Interoperability with NIH data ecosystem and controlled-access data management - Support for emerging technologies and complex, reproducible analysis workflows - No specific OEMs or vendors are named, as this is a grant forecast for platform development and enhancement.

Description

The National Human Genome Research Institute (NHGRI) intends to issue a Notice of Funding Opportunity (NOFO) for a limited competition renewal of the Analysis, Visualization, and Informatics Lab-space (AnVIL) program. AnVIL is a secure, cloud-based platform that enables researchers to access, share, and analyze large-scale genomic datasets without relying on local infrastructure. The renewed program will focus on enhancing scalability, interoperability, security, and integration of emerging data types and computational tools, including AI-based methods. It will also expand training and outreach to help researchers effectively use AnVIL's datasets and analysis capabilities, aiming to accelerate discovery and strengthen the genomics community's capacity for clinical and translational science.

View original listing